Endocyte, Inc. (ECYT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.10-0.17 (-5.20%)
At close: 4:00 PM EDT
People also watch:
ACRXINFIAEGRCLVSMACK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.25
Prev Close3.27
Bid2.81 x 300
Ask3.51 x 200
Day's Range2.98 - 3.38
52wk Range2.65 - 5.70
1y Target EstN/A
Market Cap131.02M
P/E Ratio (ttm)-2.97
Beta1.16
Volume297,812
Avg Vol (3m)142,295
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire9 days ago

    Endocyte Announces Presentations at the 252nd American Chemical Society National Meeting & Exposition

    WEST LAFAYETTE, Ind., Aug. 15, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that five posters ...

  • Capital Cube9 days ago

    ETF’s with exposure to Endocyte, Inc. : August 15, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Endocyte, Inc. Here are 5 ETF’s with the largest exposure to ECYT-US. Comparing the performance and risk of Endocyte, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube12 days ago

    Endocyte, Inc. :ECYT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Endocyte, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Endocyte, Inc. – Amgen Inc., Johnson & Johnson, Merck & Co., Inc., Nektar Therapeutics, General Electric Company, Cerulean Pharma, Inc., AbbVie, Inc. and Verastem, Inc. (AMGN-US, JNJ-US, ... Read more (Read more...)